AU5996996A - Al/fe-treatment of a protein solution, followed by membrane concentration - Google Patents

Al/fe-treatment of a protein solution, followed by membrane concentration

Info

Publication number
AU5996996A
AU5996996A AU59969/96A AU5996996A AU5996996A AU 5996996 A AU5996996 A AU 5996996A AU 59969/96 A AU59969/96 A AU 59969/96A AU 5996996 A AU5996996 A AU 5996996A AU 5996996 A AU5996996 A AU 5996996A
Authority
AU
Australia
Prior art keywords
protein solution
treatment
followed
membrane concentration
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59969/96A
Other languages
English (en)
Inventor
Mads Aage Laustsen
Niels-Viktor Nielsen
Torben Kjaarsgaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5996996A publication Critical patent/AU5996996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU59969/96A 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration Abandoned AU5996996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK62695 1995-06-02
DK626/95 1995-06-02
PCT/DK1996/000229 WO1996038469A1 (en) 1995-06-02 1996-05-31 Al/Fe-TREATMENT OF A PROTEIN SOLUTION, FOLLOWED BY MEMBRANE CONCENTRATION

Publications (1)

Publication Number Publication Date
AU5996996A true AU5996996A (en) 1996-12-18

Family

ID=8095720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59969/96A Abandoned AU5996996A (en) 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration

Country Status (9)

Country Link
EP (1) EP0828753B1 (en:Method)
JP (1) JPH11511118A (en:Method)
CN (1) CN1114613C (en:Method)
AT (1) ATE235506T1 (en:Method)
AU (1) AU5996996A (en:Method)
DE (1) DE69626976T2 (en:Method)
DK (1) DK0828753T3 (en:Method)
IN (1) IN181859B (en:Method)
WO (1) WO1996038469A1 (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810667B1 (fr) * 2000-06-23 2004-09-03 Warner Lambert Co Procede d'isolement et de purification d'une proteine, et proteine obtenue
DK1370674T3 (da) 2001-02-21 2011-08-29 Verenium Corp Enzymer med alfa-amylase-aktivitet samt fremgangsmåder til anvendelse deraf
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
WO2002092802A1 (en) * 2001-05-14 2002-11-21 Diversa Corporation Novel methods of enzyme purification
DE60224284T2 (de) 2001-06-28 2008-12-18 Novo Nordisk A/S Stabile formulierung von modifiziertem glp-1
US7118891B2 (en) 2001-12-11 2006-10-10 Novozymes A/S Crystal harvest from fermentation broth
CN100487114C (zh) * 2001-12-11 2009-05-13 诺维信公司 从发酵液收获晶体
WO2004091544A2 (en) 2003-03-06 2004-10-28 Diversa Corporation Amylases, nucleic acids encoding them and methods for making and using them
CN102940879B (zh) 2003-06-03 2017-06-06 诺沃挪第克公司 稳定化的药物肽组合物
EP1633391B1 (en) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
MXPA06005581A (es) 2003-11-20 2006-08-11 Novo Nordisk As Formulaciones de peptidos que contienen propilenglicol que son optimas para la produccion y uso en dispositivos de inyeccion.
US8710181B2 (en) 2004-08-31 2014-04-29 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
CN105832658B (zh) 2004-11-12 2020-07-31 诺和诺德公司 促胰岛素肽的稳定制剂
US7855280B2 (en) * 2005-09-15 2010-12-21 Wyeth Llc Separation methods
MX2009006782A (es) 2006-12-21 2009-09-21 Verenium Corp Amilasas y glucoamilasas, acidos nucleicos que las codifican y metodos para formarlas y usarlas.
TW201303022A (zh) * 2011-03-29 2013-01-16 Danisco Us Inc 泡沫控制的方法
DK2914611T3 (en) * 2012-11-01 2018-12-10 Novozymes As Method of DNA Removal
CN105745217A (zh) 2013-11-19 2016-07-06 凯米罗总公司 减少生物技术液体的颜色的方法
MA46990B1 (fr) 2017-08-24 2024-03-29 Novo Nordisk As Compositions glp-1 et ses utilisations
CN108949703A (zh) * 2018-06-28 2018-12-07 大连理工大学 一种半纤维小体类似物粗提纯方法
WO2020249546A1 (en) 2019-06-13 2020-12-17 Basf Se Method of recovering a protein from fermentation broth using a divalent cation
KR20220143036A (ko) 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 약학적 제형
EP4217366A1 (en) 2020-09-22 2023-08-02 Basf Se Method for recovering a protein from a fermentation broth comprising a high degree of lysed cells
CN112500471B (zh) * 2020-12-22 2022-09-27 中美华世通生物医药科技(武汉)股份有限公司 一种制备高澄清度蛋白琥珀酸铁的方法
CN119654420A (zh) 2022-08-02 2025-03-18 巴斯夫欧洲公司 使用芽孢杆菌宿主细胞的稳定的蛋白质生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795586A (en) * 1969-08-11 1974-03-05 Pabst Brewing Co Recovery of enzymes
IL85255A0 (en) * 1987-01-30 1988-07-31 Int Minerals & Chem Corp Recovery of somatotropin from dilute aqueous solutions
US4894444A (en) * 1987-07-16 1990-01-16 Merck & Co., Inc. Recovery and purification of immunogens from immunogen-alum complexes
DE3915277A1 (de) * 1989-05-10 1990-11-15 Henkel Kgaa Verfahren zur reinigung von enzymfluessigkonzentraten
DE4037530A1 (de) * 1990-11-26 1992-05-27 Henkel Kgaa Faellungsverfahren fuer exocellulaere proteine
DK91092D0 (en:Method) * 1992-07-10 1992-07-10 Novo Nordisk As

Also Published As

Publication number Publication date
DE69626976D1 (de) 2003-04-30
CN1186498A (zh) 1998-07-01
ATE235506T1 (de) 2003-04-15
EP0828753A1 (en) 1998-03-18
JPH11511118A (ja) 1999-09-28
WO1996038469A1 (en) 1996-12-05
EP0828753B1 (en) 2003-03-26
CN1114613C (zh) 2003-07-16
DK0828753T3 (da) 2003-06-30
IN181859B (en:Method) 1998-10-03
DE69626976T2 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
CA2287267A1 (en) Improved methods for processing activated protein c
BR9608729A (pt) Preparação de um pó de proteína acilada
MY127603A (en) Method to remove citrate and aluminum from proteins
WO1997003204A3 (de) (s)-hydroxynitrillyase aus hevea brasiliensis
AU4876196A (en) A process for the preparation of factor ix from biological sources
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
KR960017852A (ko) 염기성 아미노산의 정제 방법
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
AU4944996A (en) Dna fragment encoding d-amino acid oxidase
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
AU7126996A (en) Aqueous solutions of formic acid, propionic acid and ammonia and the use thereof
AU4654097A (en) Rdgb-proteins
MX9600831A (es) Procedimiento para la preparacion de acido 3-cloropropionico.
ES2166545T3 (es) Procedimiento de preparacion de un aminoacido activado.
WO1998030687A3 (de) Srcr domäne-enthaltendes protein
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
AU8941091A (en) Method for purifying concentrated, aqueous and used solutions of chromic acid, and solutions thereby purified
DE3270177D1 (en) Process for purifying elastase
SE9702993D0 (sv) Anti-mikrobial komposition
AU6661394A (en) Purification of fluoronucleosides
UA8125A1 (uk) Спосіб підготовки води